Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.390
-0.280 (-16.77%)
At close: Nov 20, 2024, 4:00 PM
1.380
-0.010 (-0.72%)
Pre-market: Nov 21, 2024, 4:39 AM EST
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $22.58 million as of November 21, 2024. Its market cap has decreased by -46.90% in one year.
Market Cap
22.58M
Enterprise Value
16.82M
1-Year Change
-46.90%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $22.58M, a decrease of -60.56%. That is a compound annual growth rate of -23.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 27.13M | -48.55% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 28.90M |
| SAB Biotherapeutics | 28.61M |
| Longeveron | 28.43M |
| ImmuCell | 28.28M |
| IRIDEX | 28.12M |
| Daré Bioscience | 27.43M |
| Marker Therapeutics | 27.39M |
| Nortech Systems | 26.88M |